Next 10 |
home / stock / irraf / irraf news
IRRAS AB (publ) press release ( OTC:IRRAF ): Q4 GAAP EPS of -SEK0.06. Revenue of SEK10.6M (+47.2% Y/Y). For further details see: IRRAS AB (publ) GAAP EPS of -SEK0.06, revenue of SEK10.6M
IRRAS AB (publ) press release ( OTC:IRRAF ): Q3 GAAP EPS of -SEK0.34. Revenue of SEK11M (+80.3% Y/Y). For further details see: IRRAS AB (publ) GAAP EPS of -SEK0.34, revenue of SEK11M
IRRAS AB (publ) press release ( OTC:IRRAF ): Q2 GAAP EPS of -SEK 0.46. Revenue of SEK 9.7M (+90.2% Y/Y). For further details see: IRRAS AB (publ) GAAP EPS of -SEK 0.46, revenue of SEK 9.7M
IRRAS Announces publication of a Case report from Buffalo General Medical Center, highlights clinical superiority of IRRAflow treatment versus traditional drainage - IRRAflow Intraventricular Hemorrhage (IVH) Case Report Published in Cureus Journal of Medical Science - Publi...
IRRAS AB (IRRAF): Q1 GAAP EPS of -SEK0.59.Revenue of SEK4M (+150.0% Y/Y)Press Release For further details see: IRRAS AB reports Q1 results
IRRAS Announces Collaboration with Aarhus University Hospital, Scandinavian Leader in Neurosurgery, to Advance Use of IRRAflow - The collaboration with Aarhus University's neurosurgical team will evaluate IRRAflow during the treatment of Intraventricular Hemorrhage (IVH) and ass...
IRRAS to Present at Redeye PR Newswire STOCKHOLM , March 23, 2021 /PRNewswire/ -- IRRAS, a global healthcare company with a comprehensive portfolio of innovative products for neurocritical care, today announced that company management will present at th...
IRRAS AB publishes Year End Report for the period January to December 2020 PR Newswire STOCKHOLM , Feb. 16, 2021 /PRNewswire/ -- Growth despite COVID-19 resurgence "During the course of the 4th quarter, challenges associated with the COVID-19 global pan...
Q4 Report 2020 - invitation to conference call and audiocast PR Newswire STOCKHOLM , Feb. 9, 2021 /PRNewswire/ -- On Tuesday February 16 , at 16.00 CET, IRRAS will host a conference call and an online presentation of its Q4 2020 interim report (which will hav...
IRRAS to Present at H.C. Wainwright Virtual BioConnect Conference PR Newswire STOCKHOLM , Jan. 5, 2021 /PRNewswire/ -- IRRAS AB, a commercial-stage medical technology company with a comprehensive portfolio of innovative products for neurocritical care, today anno...
News, Short Squeeze, Breakout and More Instantly...
Irras AB Company Name:
IRRAF Stock Symbol:
OTCMKTS Market:
IRRAS Announces publication of a Case report from Buffalo General Medical Center, highlights clinical superiority of IRRAflow treatment versus traditional drainage - IRRAflow Intraventricular Hemorrhage (IVH) Case Report Published in Cureus Journal of Medical Science - Publi...
IRRAS Announces Collaboration with Aarhus University Hospital, Scandinavian Leader in Neurosurgery, to Advance Use of IRRAflow - The collaboration with Aarhus University's neurosurgical team will evaluate IRRAflow during the treatment of Intraventricular Hemorrhage (IVH) and ass...
IRRAS to Present at Redeye PR Newswire STOCKHOLM , March 23, 2021 /PRNewswire/ -- IRRAS, a global healthcare company with a comprehensive portfolio of innovative products for neurocritical care, today announced that company management will present at th...